Food, Pharmaceutical & Bioengineering Division

Monday, November 17, 2008
Session 9 - Advances In Biocatalysis I
Session 12 - Advances In Metabolic Engineering and Bioinformatics I
Session 14 - Biobased Fuels and ChEmicals I Cosponsored by: T4 Topical 4: Sustainable Biorefineries
Session 18 - Biosensors, Bioprocess Monitoring and Control
Session 41 - Intracellular Processes I
Session 44 - Mems and Biosensors I
Session 64 - Advances In Biocatalysis II
Session 66 - Advances in Metabolic Engineering and Bioinformatics II
Session 68 - API Drug Formulation and Delivery
Session 69 - Biobased Fuels and ChEmicals II Cosponsored by: T4 Topical 4: Sustainable Biorefineries
Session 92 - Intracellular Processes II
Session 98 - Mems and Biosensors II
Session 126 - Thermodynamics of Protein Folding and Aggregation
Session 146 - Environmental Biotechnology: Green Bioprocessing Cosponsored by: T4 Topical 4: Sustainable Biorefineries
Session 160 - Modeling, Analysis and Control In Biomedicine
Session 176 - Quality by Design In the Pharmaceutical Industry Cosponsored by: 12 Process Development Division
Session 178 - Scale-up Issues in Pharmaceutical Formulation Development
Tuesday, November 18, 2008
Session 194 - Advances In Cell Culture I
Session 197 - Advances in Metabolic Engineering and Bioinformatics III
Session 210 - Cell Adhesion and Migration I
Session 214 - Drug Delivery I Cosponsored by: 15d Engineering Fundamentals in Life Science
Session 242 - Protein Engineering I: Therapeutics
Session 255 - Quality by Design- Invited Talks and Round Table Discussion Cosponsored by: 12 Process Development Division
Session 261 - Advances in API Process Development
Session 263 - Advances In Cell Culture II
Session 275 - Cell Adhesion and Migration II
Session 283 - Drug Delivery II
Session 300 - Metabolic Engineering for Tissues and Organs
Session 313 - Protein Engineering II: Computational Approaches
Session 342 - Drug Delivery III
Session 350 - Genomics and Proteomics for Tissues and Organs
Session 360 - Mixing Issues In the Pharmaceutical Industry Cosponsored by: 06 North American Mixing Forum
Session 375 - Protein Engineering III
Session 376 - Reaction Engineering in Pharmaceuticals and Fine ChEmicals Cosponsored by: 20 Catalysis and Reaction Engineering Division
Session 378 - Stem Cells in Tissue Engineering I
Wednesday, November 19, 2008
Session 392 - Advances In Protein Expression and Post-Translational Modification
Session 405 - Crystallization of Pharmaceutical and Biological Molecules I Cosponsored by: 02b Crystallization and Evaporation
Session 414 - Gene Delivery I
Session 425 - Molecular Modeling of Biophysical Processes I Cosponsored by: 21 Computational Molecular Science and Engineering Forum
Session 432 - New Approaches In Upstream Bioprocessing: Development and Manufacturing
Session 446 - Stem Cells In Tissue Engineering II
Session 473 - Crystallization of Pharmaceutical and Biological Molecules II Cosponsored by: 02b Crystallization and Evaporation
Session 478 - Gene Delivery II
Session 480 - Innovations in Biopharmaceutical Process Development
Session 489 - Molecular Modeling of Biophysical Processes II Cosponsored by: 21 Computational Molecular Science and Engineering Forum
Session 504 - Protein Structure, Function and Stability I
Session 507 - Receptor-Mediated Phenomena I
Session 536 - Food, Pharmaceutical and Bioengineering Plenary Session Cosponsored by: T4 Topical 4: Sustainable Biorefineries
Session 567 - Food, Pharmaceutical and Bioengineering Division Forum
Session 569 - Pharmaceuticals Poster Session
Session 571 - Poster Session: Bioengineering
Session 572 - Poster Session: Engineering Fundamentals in Life Sciences
Thursday, November 20, 2008
Session 579 - Biomaterial-Cell Interactions in Tissue Engineering I
Session 587 - Disease Therapies and Diagnostics I
Session 601 - Innovations in Pharmaceutical Process Development
Session 607 - Modeling in the Pharmaceutical Industry I
Session 618 - Protein Structure, Function and Stability II
Session 620 - Systems Biotechnology I
Session 638 - Continuous Processing in the ChEmical and Pharmaceutical Industry Cosponsored by: 03a Particle Production and Characterization
Session 640 - Disease Therapies and Diagnostics II
Session 651 - Modeling in the Pharmaceutical Industry II
Session 658 - Novel Methods and Analysis of Biochemical High Throughput Screens
Session 670 - Receptor-Mediated Phenomena II
Session 673 - Systems Biotechnology II
Session 677 - Advances in Fermentation/ Biological Conversion I Cosponsored by: T4 Topical 4: Sustainable Biorefineries
Session 679 - Biomaterial-Cell Interactions in Tissue Engineering II
Session 693 - High Throughput Technologies
Session 698 - Mathematical Approaches in Systems Biology
Session 710 - PAT Implementation in Formulation Development
Session 712 - Population Balance Modeling of Particulate Processes in the Pharmaceutical Industry
Friday, November 21, 2008
Session 726 - Bioseparations and Downstream Bioprocessing I Cosponsored by: 15b Pharmaceuticals
Session 729 - Engineering Biomolecules
Session 730 - Food Processing and Safety
Session 737 - Modeling Approaches to Examine Topics In Life Science I
Session 744 - Science and Engineering in Crystallization Cosponsored by: 02b Crystallization and Evaporation
Session 749 - Disease Mechanisms
Session 751 - Advances in Fermentation/ Biological Conversion II Cosponsored by: T4 Topical 4: Sustainable Biorefineries
Session 756 - Bioseparations and Downstream Bioprocessing II Cosponsored by: 15b Pharmaceuticals
Session 765 - Modeling Appraoches to Examine Topics In Life Science II
Session 767 - Nanotechnology in the Realm of Food Science
Session 769 - PAT Applications in Pharmaceuticals

See more of The 2008 Annual Meeting